Mark Rubinstein to B7-H1 Antigen
This is a "connection" page, showing publications Mark Rubinstein has written about B7-H1 Antigen.
Connection Strength
0.202
-
Converting Tumoral PD-L1 into a 4-1BB Agonist for Safer and More Effective Cancer Immunotherapy. Cancer Discov. 2022 05 02; 12(5):1184-1186.
Score: 0.202
Connection Strength
The connection strength for concepts is the sum of the scores for each matching publication.
Publication scores are based on many factors, including how long ago they were written and whether the person is a first or senior author.